Amylyx Enrolls First ALS Patients in Phase 2 Extension Trial of AMX0035
The first patients to complete a Phase 2 clinical trial have chosen to continue treatment in an open-label extension (OLE)…
Articles by Margarida Azevedo, MSc
Elysium Health’s EH301 Designated Orphan Drug by FDA for Treatment of ALS
EH301, Elysium Health‘s investigational therapy for amyotrophic lateral sclerosis (ALS), was recently granted orphan drug status by the U.S.
BrainStorm Adds Canadians to U.S. Trial of Its ALS Stem Cell Therapy
BrainStorm Cell Therapeutics is adding Canadians to a Phase 3 U.S. clinical trial of its ALS stem cell therapy NurOwn.
Prothena and Celgene to Work Together on ALS Therapies
Prothena and Celgene are teaming up to develop treatments for a range of neurodegenerative diseases, including amyotrophic lateral sclerosis…
ALS and Huntington’s Groups Join Teva in Issuing Global Research Challenge
Three organizations that are fighting neurodegenerative disorders have teamed up to challenge researchers around the world to come up with…
Montreal Neurological Institute and Thermo Fisher Scientific Partner to Accelerate Understanding of Brain Diseases
The Montreal Neurological Institute of McGill University and Thermo Fisher Scientific have recently partnered to…
Orangetheory Fitness Clubs in US, Canada to Plan Fundraiser for Augie’s Quest and ALS Research
Orangetheory fitness members across the United States and Canada plan to raise $2 million for Augie’s Quest to cure…
Sangamo and Pfizer to Collaborate on Developing Gene Therapies for ALS
Sangamo Therapeutics and Pfizer will work together on gene therapies they hope will overcome mutations that cause ALS…
Top 10 ALS News Stories of 2017
Throughout 2017, ALS News Today brought you daily coverage of amyotrophic lateral sclerosis (ALS)-related advocacy events, clinical studies, and…
Startups Working in ALS, Immunotherapy Win ‘Amgen Golden Tickets’ to Advance Discoveries
Two young companies, QurAlis and Kernal Biologics, are winners of the Amgen Golden Tickets for innovative bioscience projects —…